AUTHOR=Qian Lihan , Xie Junjie , Xu Zhiwei , Deng Xiaxing , Chen Hao , Peng Chenghong , Li Hongwei , Chai Weimin , Xie Jing , Wang Weishen , Shen Baiyong 

TITLE=The Necessity of Dissection of No. 14 Lymph Nodes to Patients With Pancreatic Ductal Adenocarcinoma Based on the Embryonic Development of the Head of the Pancreas

JOURNAL=Frontiers in Oncology

VOLUME=10

YEAR=2020

URL=https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2020.01343

DOI=10.3389/fonc.2020.01343

ISSN=2234-943X

ABSTRACT=<p><bold>Objectives:</bold> Pancreaticoduodenectomy (PD) followed by lymphadenectomy is performed for patients with pancreatic ductal adenocarcinoma (PDAC) located in the head of the pancreas. Because the head of the pancreas could be divided into dorsal or ventral primordium in relation to embryonic development, the metastasis of lymph node (LN) may differ. In this retrospective study, we evaluated the impact of extended or standard LN dissection for PDAC located in ventral or dorsal primordia of the pancreatic head.</p><p><bold>Methods:</bold> From February 2016 to November 2018, 178 patients who underwent PD for PDAC were enrolled at the Pancreatic Disease Center, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University. According to the tumor location and the range of LN dissection, all patients were divided into three groups: ventral primordium with extended lymphadenectomy (VE group), ventral primordium with standard lymphadenectomy (VS group), and dorsal primordium with extended lymphadenectomy (DE group). Clinical and pathological features were retrospectively analyzed as were the long-term survival outcomes.</p><p><bold>Results:</bold> More patients in the VE group were detected with metastasis in the lymph nodes around the superior mesenteric artery (LN14) than those in the DE group (LN along the right side of the superior mesenteric artery, LN14ab): 22.9 vs. 5.9%, <italic>p</italic> = 0.005; (LN along the left side of the superior mesenteric artery, LN14cd): 10.0 vs. 0.0%, <italic>p</italic> = 0.022. LN14 was involved in more patients in the VE group than in the VS group (22.9 vs. 5.0%, <italic>p</italic> = 0.015). For IIb-stage patients in the VE group, the overall survival time (18.3 vs. 9.3 months, <italic>p</italic> &lt; 0.001) and disease-free survival time (12.2 vs. 5.1 months, <italic>p</italic> = 0.045) were longer in those with LN14cd (–) than those with LN14cd (+).</p><p><bold>Conclusion:</bold> This study suggested that patients with PDAC located in the ventral head of the pancreas had higher risk of LN14 involvement compared with those at dorsal. Thus, a thorough dissection of LN14 in PDAC located in the ventral head of the pancreas is recommended to optimize the regional extended lymphadenectomy.</p>